Tjoapack receives investment from Ampersand Capital Partners

Tjoapack has immediate plans to invest in expanding its automated packaging capabilities, including for injectable products, allowing the company to cater to market demand for prefilled syringes and vial packaging

picture of Dexter Tjoa

Breaking News

Symbiosis Pharmaceutical Services raises $1.25m

Scotland-based sterile manufacturing services provider has received finance from Allied Irish Bank (GB) to support its ...

Catalent expands beauty and plant-based consumer health softgel capabilities in Canada and Brazil

Catalent has announced the completion of a $3.2 million expansion programme at its consumer health manufacturing ...

CPhI plans 'Pharma Festival' digital experience to replace postponed worldwide event

Informa have agreed with key partners to adapt to a digital format in 2020, a large-scale digital exhibition that will ...

BioCity predicts proliferation of workspace amid life science ventures boom

The UK's life science incubator has released the Life Science Start-Up Report with in-depth analysis of emerging ...

Base Genomics launch raises $11m to commercialise epigenetic technology

Base Genomics has plans to use epigenetic technology for early and sensitive detection of cancer from liquid biopsy

Marinomed plans entrance into Italian cold remedy market

Vienna-based Marinomed Biotech is expanding into the Italian market for cold remedies via its Carragelose products

Beximco Pharma: The Bangladeshi company connecting with the US

COO Rabbur Reza talks about the strategy behind approaching pharmaceutical manufacturing from an emerging market

Almac Group supports two COVID-19 clinical studies in sub-Saharan Africa

Grant awarded from the COVID-19 Therapeutics Accelerator, an Initiative by the Bill & Melinda Gates Foundation, ...

Beximco Pharma introduces first generic remdesivir for COVID-19

Beximco Pharma is donating remdesivir (Bemsivir) to the Bangladesh Government for supply only to Government hospitals

What happens if a company doesn’t have any records of its R&D activities?

Companies in the UK engaged in R&D can get up to 33% of innovation expenditures back. Myriad Associates explains how to ...

Addressing the need for cost-effective vaccine manufacturing

Process intensification and integrated continuous bioprocessing are two approaches that can be used to achieve cost- ...

An automatic response to businesses’ financial woes

The UK business world is in crisis. It might sound like an over-dramatic statement; however, from a financial ...

Catalent acquires Japanese facility to provide local and global clinical supply solutions

Purchase will establish a new clinical GMP manufacturing and distribution hub to support clinical studies

WuXi Biologics closes deal to build biomanufacturing hub in the US

China-based WuXi Biologics has agreed to build its 107,000 sqft clinical and commercial manufacturing facility in ...